Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

570
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
570
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

976
Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
976
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

1.6K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.6K
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

880
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
880
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

1.6K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
1.6K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ventilator Liberation for Hospitalized Patients With Tracheostomy.

Respiratory care·2026
Same author

Incidence and Outcomes of Refractory Septic Shock per Consensus Clinical Criteria: A Multicohort Retrospective Study.

Critical care medicine·2026
Same author

Implementation and Assessment of a Novel Interprofessional Educational Initiative in the Medical Intensive Care Unit: A Mixed-Methods Evaluation.

ATS scholar·2026
Same author

The Weight of the Situation: The Case for Standardizing Vasopressor Dosing Units.

Critical care medicine·2026
Same author

Fighting ageism: Preserving patient agency in critical care.

Cleveland Clinic journal of medicine·2026
Same author

Defining and Measuring Patient-Ventilator Interactions: 10 Fundamental Maxims.

Respiratory care·2026

Related Experiment Video

Updated: Jan 13, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.1K

Ketamine for Severe Asthma Exacerbation.

Emily M Wagner1, Gretchen L Sacha1, Eduardo Mireles-Cabodevila2

  • 1Department of Pharmacy, Cleveland Clinic, Cleveland, OH.

Critical Care Explorations
|January 9, 2026
PubMed
Summary
This summary is machine-generated.

Continuous ketamine infusion did not improve carbon dioxide levels in patients with severe asthma exacerbations. This study evaluated its effects on gas exchange and safety outcomes in intubated adults.

Keywords:
asthmabronchodilationintubationketaminemechanical ventilation

More Related Videos

In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells
04:56

In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells

Published on: October 23, 2018

7.0K
Topical Airway Anesthesia for Awake-endoscopic Intubation Using the Spray-as-you-go Technique with High Oxygen Flow
05:43

Topical Airway Anesthesia for Awake-endoscopic Intubation Using the Spray-as-you-go Technique with High Oxygen Flow

Published on: January 13, 2017

17.1K

Related Experiment Videos

Last Updated: Jan 13, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.1K
In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells
04:56

In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells

Published on: October 23, 2018

7.0K
Topical Airway Anesthesia for Awake-endoscopic Intubation Using the Spray-as-you-go Technique with High Oxygen Flow
05:43

Topical Airway Anesthesia for Awake-endoscopic Intubation Using the Spray-as-you-go Technique with High Oxygen Flow

Published on: January 13, 2017

17.1K

Area of Science:

  • Critical Care Medicine
  • Pulmonology
  • Pharmacology

Background:

  • Severe asthma exacerbations (SAEs) often require mechanical ventilation.
  • Continuous infusion ketamine is used in intensive care units (ICUs) for various indications.
  • Limited data exists on ketamine's impact on gas exchange in intubated SAE patients.

Purpose of the Study:

  • To assess the effect of continuous ketamine infusion on Pco2 levels in intubated patients with SAEs.
  • To evaluate changes in pH, ventilator requirements, and safety outcomes.
  • To determine if ketamine improves gas exchange during severe asthma exacerbations.

Main Methods:

  • Retrospective observational study of 38 intubated patients (≥18 years) with SAEs.
  • Patients received continuous ketamine infusion for ≥1 hour.
  • Primary outcome: change in Pco2 before and after ketamine initiation.

Main Results:

  • Median Pco2 was 67.65 mm Hg before and 64 mm Hg after ketamine (p-value not specified).
  • Median pH increased slightly from 7.21 to 7.24.
  • Adverse events included tachycardia (52.6%), hypotension (50%), and emergence reactions (13.2%); mortality was 15.8%.

Conclusions:

  • Continuous ketamine infusion did not significantly improve Pco2 levels in intubated patients with SAEs.
  • Ketamine use was associated with significant rates of tachycardia and hypotension.
  • Further research is needed to clarify ketamine's role in managing severe asthma exacerbations.